Lilly(Eli) & Co

NYSE:LLY  
230.04
-1.00 (-0.43%)
4:00:00 PM EDT: $229.97 -0.07 (-0.03%)
Products

FDA Grants Jardiance Breakthrough Therapy Designation For Heart Failure With Preserved Ejection Fraction

Published: 09/09/2021 12:21 GMT
Lilly(Eli) & Co (LLY) - FDA Grants Jardiance® Breakthrough Therapy Designation for Heart Failure With Preserved Ejection Fraction.